Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 170,284,928
  • Shares Outstanding, K 537,329
  • Annual Sales, $ 28,190 M
  • Annual Income, $ 6,717 M
  • EBIT $ 6,218 M
  • EBITDA $ 10,289 M
  • 60-Month Beta 0.60
  • Price/Sales 6.08
  • Price/Cash Flow 12.11
  • Price/Book 22.79

Options Overview Details

View History
  • Implied Volatility 44.88% ( +0.56%)
  • Historical Volatility 21.78%
  • IV Percentile 97%
  • IV Rank 92.55%
  • IV High 47.03% on 10/28/24
  • IV Low 18.08% on 11/30/23
  • Put/Call Vol Ratio 1.30
  • Today's Volume 615
  • Volume Avg (30-Day) 8,800
  • Put/Call OI Ratio 1.03
  • Today's Open Interest 183,971
  • Open Int (30-Day) 175,250

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 4.49
  • Number of Estimates 13
  • High Estimate 5.43
  • Low Estimate -2.41
  • Prior Year 4.71
  • Growth Rate Est. (year over year) -4.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
310.63 +2.24%
on 10/30/24
329.17 -3.52%
on 10/11/24
-2.07 (-0.65%)
since 10/04/24
3-Month
306.59 +3.59%
on 08/07/24
339.17 -6.36%
on 09/23/24
-7.63 (-2.34%)
since 08/05/24
52-Week
260.52 +21.91%
on 11/21/23
346.85 -8.43%
on 07/25/24
+47.74 (+17.69%)
since 11/03/23

Most Recent Stories

More News
Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus

Amgen AMGN reported third-quarter 2024 adjusted earnings of $5.58 per share, which beat the Zacks Consensus Estimate of $5.11. Earnings rose 13% year over year as higher revenues offset the impact of higher...

AZN : 65.88 (-7.77%)
NVO : 109.09 (-0.57%)
LLY : 799.10 (-0.87%)
AMGN : 317.28 (+0.12%)
Amgen (AMGN) Q3 2024 Earnings Call Transcript

AMGN earnings call for the period ending September 30, 2024.

AMGN : 317.28 (+0.12%)
Amgen: Q3 Earnings Snapshot

Amgen: Q3 Earnings Snapshot

AMGN : 317.28 (+0.12%)
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split

One of these players has split its stock in the past. The other one hasn't.

NVDA : 139.39 (+2.45%)
LLY : 799.10 (-0.87%)
GS : 518.20 (+1.32%)
CMG : 56.69 (+0.55%)
REGN : 826.57 (-0.27%)
AMGN : 317.28 (+0.12%)
WMT : 83.53 (+1.31%)
SNY : 52.70 (-0.47%)
2 Reliable Dividend Stocks You Can Buy and Hold Forever

There are reasons beyond the dividends to invest in these stocks.

MA : 505.67 (+0.02%)
V : 293.72 (+0.64%)
AMGN : 317.28 (+0.12%)
Health and Wellness Sector Sees New Opportunities in Weight Loss Drug Market

Issued on behalf of PlantX Life Inc. VANCOUVER – USA News Group News Commentary – With over 100 million Americans facing obesity and rates rising globally, it’s no surprise that analysts...

WW : 1.1450 (-3.78%)
HLF : 8.08 (-1.82%)
MS : 117.07 (+0.80%)
MED : 19.12 (+1.65%)
VEGA.CN : 0.3500 (-6.67%)
PLTXF : 0.2660 (-15.10%)
AMGN : 317.28 (+0.12%)
3 Top Healthcare Stocks to Buy for Growth and Dividends

Investors seeking growth and dividend income in the healthcare sector may want to consider Eli Lilly, Gilead Sciences, and Amgen, which have delivered impressive returns and boast strong pipelines and...

UHS : 209.49 (+0.32%)
LLY : 799.10 (-0.87%)
GILD : 89.79 (-0.06%)
ISRG : 516.39 (+1.77%)
AMGN : 317.28 (+0.12%)
DVA : 145.38 (+0.30%)
Amgen Gears Up to Report Q3 Earnings: Here's What to Expect

Amgen AMGN will report third-quarter 2024 results on Oct. 30, after market close. In the last reported quarter, the company beat earnings expectations by 0.81%.The Zacks Consensus Estimate for sales and...

REGN : 826.57 (-0.27%)
AMGN : 317.28 (+0.12%)
PFE : 27.78 (+0.07%)
BIIB : 175.93 (+1.39%)
Is Amgen Stock a Buy?

This biotech leader could be poised to rally higher.

AMGN : 317.28 (+0.12%)
Lilly Loses Around $14B This Week: How to Play LLY Stock

The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value. Earlier this month, the FDA removed Lilly’s popular GLP-1 drug tirzepatide from...

NVO : 109.09 (-0.57%)
LLY : 799.10 (-0.87%)
AMGN : 317.28 (+0.12%)
BIIB : 175.93 (+1.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 326.09
2nd Resistance Point 323.34
1st Resistance Point 320.12
Last Price 317.28
1st Support Level 314.15
2nd Support Level 311.40
3rd Support Level 308.18

See More

52-Week High 346.85
Last Price 317.28
Fibonacci 61.8% 313.87
Fibonacci 50% 303.68
Fibonacci 38.2% 293.50
52-Week Low 260.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar